Mateon Therapeutics, Inc. (MATN) - NASDAQ
From other sites
Company Description
Oxigene, Inc. engages in the development of therapeutics to treat cancer and eye diseases. The company is a clinical-stage, biopharmaceutical company developing novel therapeutics primarily to treat cancer. It offers anti-vascular drugs referred to as vascular disrupting agents. The company was... More
Sector: Healthcare
Industry: Biotechnology
Country: United States